| 000 | 01679 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517065359.0 | ||
| 264 | 0 | _c20170210 | |
| 008 | 201702s 0 0 eng d | ||
| 022 | _a2567-689X | ||
| 024 | 7 |
_a10.1160/TH15-08-0683 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHarrington, Laura B | |
| 245 | 0 | 0 |
_aThe association of F11 genetic variants with the risk of incident venous thrombosis among women, by statin use. _h[electronic resource] |
| 260 |
_bThrombosis and haemostasis _cMar 2016 |
||
| 300 |
_a682-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aFactor XI _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenetic Variation |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSex Factors |
| 650 | 0 | 4 |
_aVenous Thrombosis _xgenetics |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aWiggins, Kerri L | |
| 700 | 1 | _aSitlani, Colleen M | |
| 700 | 1 | _aBlondon, Marc | |
| 700 | 1 | _avan Hylckama Vlieg, Astrid | |
| 700 | 1 | _aRosendaal, Frits R | |
| 700 | 1 | _aHeckbert, Susan R | |
| 700 | 1 | _aPsaty, Bruce M | |
| 700 | 1 | _aSmith, Nicholas L | |
| 773 | 0 |
_tThrombosis and haemostasis _gvol. 115 _gno. 3 _gp. 682-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1160/TH15-08-0683 _zAvailable from publisher's website |
| 999 |
_c25509540 _d25509540 |
||